Matches in SemOpenAlex for { <https://semopenalex.org/work/W4324146573> ?p ?o ?g. }
- W4324146573 abstract "The leukemia inhibitory factor (LIF), is a cytokine belonging to IL-6 family, whose overexpression correlate with poor prognosis in cancer patients, including pancreatic ductal adenocarcinoma (PDAC). LIF signaling is mediate by its binding to the heterodimeric LIF receptor (LIFR) complex formed by the LIFR receptor and Gp130, leading to JAK1/STAT3 activation. Bile acids are steroid that modulates the expression/activity of membrane and nuclear receptors, including the Farnesoid-X-Receptor (FXR) and G Protein Bile Acid Activated Receptor (GPBAR1).Herein we have investigated whether ligands to FXR and GPBAR1 modulate LIF/LIFR pathway in PDAC cells and whether these receptors are expressed in human neoplastic tissues.The transcriptome analysis of a cohort of PDCA patients revealed that expression of LIF and LIFR is increased in the neoplastic tissue in comparison to paired non-neoplastic tissues. By in vitro assay we found that both primary and secondary bile acids exert a weak antagonistic effect on LIF/LIFR signaling. In contrast, BAR502 a non-bile acid steroidal dual FXR and GPBAR1 ligand, potently inhibits binding of LIF to LIFR with an IC50 of 3.8 µM.BAR502 reverses the pattern LIF-induced in a FXR and GPBAR1 independent manner, suggesting a potential role for BAR502 in the treatment of LIFR overexpressing-PDAC." @default.
- W4324146573 created "2023-03-15" @default.
- W4324146573 creator A5016318817 @default.
- W4324146573 creator A5018930736 @default.
- W4324146573 creator A5031806192 @default.
- W4324146573 creator A5033525624 @default.
- W4324146573 creator A5037630349 @default.
- W4324146573 creator A5038809461 @default.
- W4324146573 creator A5040613191 @default.
- W4324146573 creator A5046961181 @default.
- W4324146573 creator A5051992892 @default.
- W4324146573 creator A5053616013 @default.
- W4324146573 creator A5057095436 @default.
- W4324146573 creator A5057720130 @default.
- W4324146573 creator A5059986730 @default.
- W4324146573 creator A5065286832 @default.
- W4324146573 creator A5065995030 @default.
- W4324146573 creator A5070852671 @default.
- W4324146573 creator A5071291514 @default.
- W4324146573 creator A5082031556 @default.
- W4324146573 creator A5086947006 @default.
- W4324146573 date "2023-03-14" @default.
- W4324146573 modified "2023-10-01" @default.
- W4324146573 title "Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma" @default.
- W4324146573 cites W1451908951 @default.
- W4324146573 cites W1557020267 @default.
- W4324146573 cites W1883117256 @default.
- W4324146573 cites W1900120061 @default.
- W4324146573 cites W1963587340 @default.
- W4324146573 cites W1968812902 @default.
- W4324146573 cites W1976161355 @default.
- W4324146573 cites W1976499671 @default.
- W4324146573 cites W1977379410 @default.
- W4324146573 cites W1985648424 @default.
- W4324146573 cites W1993444408 @default.
- W4324146573 cites W1993515289 @default.
- W4324146573 cites W1996348049 @default.
- W4324146573 cites W1999477673 @default.
- W4324146573 cites W2000465781 @default.
- W4324146573 cites W2014139160 @default.
- W4324146573 cites W2015688756 @default.
- W4324146573 cites W2022380356 @default.
- W4324146573 cites W2029667189 @default.
- W4324146573 cites W2029669343 @default.
- W4324146573 cites W2049169935 @default.
- W4324146573 cites W2053581007 @default.
- W4324146573 cites W2055225975 @default.
- W4324146573 cites W2066657532 @default.
- W4324146573 cites W2073504771 @default.
- W4324146573 cites W2074250272 @default.
- W4324146573 cites W2085509821 @default.
- W4324146573 cites W2085636773 @default.
- W4324146573 cites W2092016723 @default.
- W4324146573 cites W2095719702 @default.
- W4324146573 cites W2096418655 @default.
- W4324146573 cites W2100096634 @default.
- W4324146573 cites W2119174526 @default.
- W4324146573 cites W2131333100 @default.
- W4324146573 cites W2134133526 @default.
- W4324146573 cites W2136714130 @default.
- W4324146573 cites W2153327715 @default.
- W4324146573 cites W2158288339 @default.
- W4324146573 cites W2158834319 @default.
- W4324146573 cites W2161355389 @default.
- W4324146573 cites W2168707849 @default.
- W4324146573 cites W2171398834 @default.
- W4324146573 cites W2201282822 @default.
- W4324146573 cites W2292760617 @default.
- W4324146573 cites W2327120009 @default.
- W4324146573 cites W2332712348 @default.
- W4324146573 cites W2404280981 @default.
- W4324146573 cites W2409321676 @default.
- W4324146573 cites W2412534268 @default.
- W4324146573 cites W2468097483 @default.
- W4324146573 cites W2516690438 @default.
- W4324146573 cites W2568780291 @default.
- W4324146573 cites W2574330890 @default.
- W4324146573 cites W2588296715 @default.
- W4324146573 cites W27140539 @default.
- W4324146573 cites W2735308840 @default.
- W4324146573 cites W2748794149 @default.
- W4324146573 cites W2765137577 @default.
- W4324146573 cites W2772225910 @default.
- W4324146573 cites W2891791233 @default.
- W4324146573 cites W2899456884 @default.
- W4324146573 cites W2901337425 @default.
- W4324146573 cites W2923192401 @default.
- W4324146573 cites W2936366750 @default.
- W4324146573 cites W2947010413 @default.
- W4324146573 cites W2966925272 @default.
- W4324146573 cites W2972602909 @default.
- W4324146573 cites W2974633814 @default.
- W4324146573 cites W2975590666 @default.
- W4324146573 cites W2991382529 @default.
- W4324146573 cites W2999417355 @default.
- W4324146573 cites W3021860171 @default.
- W4324146573 cites W3023992505 @default.
- W4324146573 cites W3042138952 @default.
- W4324146573 cites W3080433061 @default.
- W4324146573 cites W3086801715 @default.